European Companies Search Engine
EU funding (€1,443,493): European Research Infrastructure on Highly Pathogenic Agents 2 Hor20 Oct 2015 EU Research and Innovation programme "Horizon"
Text
European Research Infrastructure on Highly Pathogenic Agents 2
ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary legal document to register the RI depending on the country voted on to host the Central Coordinating Unit. ERINHA2 will prepare all procedures and protocols (human resources, IPR, ethics) needed to effectively operate the RI. The financial and business plans prepared in ERINHA (PP1) will updated and presented to national and international stakeholders to obtain their agreement to fund the infrastructure. An overarching group of activities - WP5, Stakeholders and commitment - will aim to accompany all partner countries in their efforts to obtain agreements and funding. This WP5 will ensure all relevant stakeholders and potential users are informed of the progress, services and benefits of ERINHA. The utlimate outcome of ERINHA2 will be the signtature of the ERINHA statutes among the founding countries to officially establish the RI and enter into the construction phase.
Funded Companies:
| Company name | Funding amount |
| Department of Health | €255,872 |
| Folkhalsomyndigheten | €62,000 |
| Hellenic Pasteur Institute | €47,187 |
| Inserm Transfert SA | €177,437 |
| Institut National de la Sante et de la Recherche Medicale | €440,881 |
| Instituto de Salud Carlos III | €144,562 |
| Instituto Nacional de Saude DR. Ricardo Jorge | €43,287 |
| Instituut Voor Tropische Geneeskunde | €101,376 |
| Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico | €41,250 |
| Medizinische Universitat Graz | €60,500 |
| Nemzeti Nepegeszsegugyi ES Gyogyszereszeti Kozpont | €36,579 |
| Spitalul Clinic DR Victor Babes Bucuresti - SVB | €32,562 |
Source: https://cordis.europa.eu/project/id/689622
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Department of Health - EU funding (€1,443,493): European Research Infrastructure on Highly Pathogenic Agents 2"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
